| ID | Sequence | Length | GC content |
|---|---|---|---|
| AAUGCGACCCGACCGCGCUGAGGCUCCAGGACCGCCCGCCAUGGCUGCA… | 2351 nt | 0.5283 | |
| AAUGCGACCCGACCGCGCUGAGGCUCCAGGACCGCCCGCCAUGGCUGCA… | 2691 nt | 0.5310 | |
| AAUGCGACCCGACCGCGCUGAGGCUCCAGGACCGCCCGCCAUGGCUGCA… | 2532 nt | 0.5276 | |
| AAUGCGACCCGACCGCGCUGAGGCUCCAGGACCGCCCGCCAUGGCUGCA… | 2486 nt | 0.5306 | |
| AAUGCGACCCGACCGCGCUGAGGCUCCAGGACCGCCCGCCAUGGCUGCA… | 2648 nt | 0.5302 | |
| AAUGCGACCCGACCGCGCUGAGGCUCCAGGACCGCCCGCCAUGGCUGCA… | 2513 nt | 0.5281 | |
| AAUGCGACCCGACCGCGCUGAGGCUCCAGGACCGCCCGCCAUGGCUGCA… | 2624 nt | 0.5290 | |
| AAUGCGACCCGACCGCGCUGAGGCUCCAGGACCGCCCGCCAUGGCUGCA… | 2667 nt | 0.5298 |
This gene encodes a cytosolic adapter protein that plays a central role in the innate and adaptive immune response. This protein functions as an essential signal transducer in the interleukin-1 and Toll-like receptor signaling pathways. These pathways regulate that activation of numerous proinflammatory genes. The encoded protein consists of an N-terminal death domain and a C-terminal Toll-interleukin1 receptor domain. Patients with defects in this gene have an increased susceptibility to pyogenic bacterial infections. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Feb 2010] CIViC Summary for MYD88 Gene
A study in humans demonstrated that the MYD88 gene was significantly upregulated in the bone marrow of severely injured trauma patients compared to both healthy controls and elective hip replacement patients, indicating its role as part of the innate immune and inflammatory transcriptomic signature following severe trauma [Kelly et al. DOI:10.1097/SHK.0000000000001826].